Info
Christoph Lengauer, CSO & Co-Founder, Curie.Bio
Join us for a hands-on workshop on how to progress your research into a biotech company. How can you best convert an exciting therapeutic idea into a successful enterprise? We'll share
- what investors look for,
- how early-stage programs can get funded,
- and where scientists most often stumble on their way from lab to company.
Bring your questions and your ideas and leave with a clearer view for your own path into biotech.
About Curie.Bio
Curie.Bio is a venture fund built to help founders discover and develop important new medicines. We do this by investing directly in existing companies, creating focused spin-outs, and helping founders build companies from the ground up. Our model combines two businesses in one: we serve as both a drug discovery copilot and an investor.
Our team of more than 100 drug hunters, drug makers, and operators works alongside founders every day to increase their chances of successfully developing new medicines. We help founders avoid critical mistakes and ensure they have the right plan, data, and story to maximize their path to value creation.
We have raised $1.2B and invest through two funds: the Seed Fund and the Breakout Fund. Our Seed Fund focuses on advancing therapies through key preclinical milestones, such as achieving in vivo proof of concept or selecting a development candidate. Our Breakout Fund focuses on advancing medicines through clinical trials to generate meaningful human activity data.
